Literature DB >> 20056183

Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve.

Sarah J Cox1, B Veronica Carr, Satya Parida, Pip A Hamblin, Helen Prentice, Bryan Charleston, David J Paton, Paul V Barnett.   

Abstract

To determine the longevity of protective immunity following a single administration of emergency vaccine, and establish whether the immune response could be enhanced by increasing the antigen payload even further, cattle were vaccinated with an A22 Iraq vaccine containing either 1x antigen payload (field dose) or 5x antigen payload. Six months post-immunisation all cattle received a homologous virus challenge. The magnitude of the virus neutralising antibody response elicited was consistent with the response to similarly formulated A serotype vaccines with a PD(50) greater than 32. All the vaccinated cattle, regardless of antigen payload, were protected from clinical disease following challenge although some cattle in both groups became sub-clinically infected. We conclude that immunisation with a single inoculation of vaccine from the UK emergency reserve can protect cattle from clinical disease for at least 6 months post-vaccination and that a boost may be unnecessary in an outbreak situation. Some animals may become sub-clinically infected but this is likely to be dependent on the severity of challenge. The study confirmed that a booster at 21 days post-vaccination was not necessary to maintain a cell-mediated response in cattle for 6 months. No increased benefits were recognised by increasing the antigen payload of this vaccine 5x. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20056183     DOI: 10.1016/j.vaccine.2009.12.065

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  8 in total

1.  Effects of regional differences and demography in modelling foot-and-mouth disease in cattle at the national scale.

Authors:  Kimberly Tsao; Stefan Sellman; Lindsay M Beck-Johnson; Deedra J Murrieta; Clayton Hallman; Tom Lindström; Ryan S Miller; Katie Portacci; Michael J Tildesley; Colleen T Webb
Journal:  Interface Focus       Date:  2019-12-13       Impact factor: 3.906

2.  Livestock vaccination programme participation among smallholder farmers on the outskirts of National Parks and Tiger Reserves in the Indian states of Madhya Pradesh and Assam.

Authors:  Andy Hopker; Naveen Pandey; Rosie Bartholomew; Abigail Blanton; Sophie Hopker; Aniruddha Dhamorikar; Jadumoni Goswami; Rebecca Marsland; Prakash Metha; Neil Sargison
Journal:  PLoS One       Date:  2021-08-27       Impact factor: 3.240

3.  Evaluation of the efficacy of a new oil-based adjuvant ISA 61 VG FMD vaccine as a potential vaccine for cattle.

Authors:  A Khorasani; O Madadgar; H Soleimanjahi; H Keyvanfar; H Mahravani
Journal:  Iran J Vet Res       Date:  2016       Impact factor: 1.376

4.  Rational engineering of recombinant picornavirus capsids to produce safe, protective vaccine antigen.

Authors:  Claudine Porta; Abhay Kotecha; Alison Burman; Terry Jackson; Jingshan Ren; Silvia Loureiro; Ian M Jones; Elizabeth E Fry; David I Stuart; Bryan Charleston
Journal:  PLoS Pathog       Date:  2013-03-27       Impact factor: 6.823

5.  Interferon-γ induced by in vitro re-stimulation of CD4+ T-cells correlates with in vivo FMD vaccine induced protection of cattle against disease and persistent infection.

Authors:  Yooni Oh; Lucy Fleming; Bob Statham; Pip Hamblin; Paul Barnett; David J Paton; Jong-Hyeon Park; Yi Seok Joo; Satya Parida
Journal:  PLoS One       Date:  2012-09-28       Impact factor: 3.240

6.  Randomised field trial to evaluate serological response after foot-and-mouth disease vaccination in Turkey.

Authors:  T J D Knight-Jones; A N Bulut; S Gubbins; K D C Stärk; D U Pfeiffer; K J Sumption; D J Paton
Journal:  Vaccine       Date:  2014-12-17       Impact factor: 3.641

7.  Mass vaccination, immunity and coverage: modelling population protection against foot-and-mouth disease in Turkish cattle.

Authors:  T J D Knight-Jones; S Gubbins; A N Bulut; K D C Stärk; D U Pfeiffer; K J Sumption; D J Paton
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

Review 8.  Towards improvements in foot-and-mouth disease vaccine performance.

Authors:  Graham J Belsham
Journal:  Acta Vet Scand       Date:  2020-05-20       Impact factor: 1.695

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.